Evidence map›Paper›PMID 27455311›Full record

ArticleNutrients2016

Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness.

Jisoo Lee, Yoo-Sun Kim, JaeHwan Lee, Seung Chul Heo, Kook Lae Lee, Sang-Woon Choi, Yuri Kim

Abstract readComparative Study
In one paragraph

Article in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Andean Berry (Molecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Dietary intake of walnut preventedJournal of clinical biochemistry and nutrition · 2021
    Article
  17. Article
  18. Walnut polyphenol extracts inhibitJournal of clinical biochemistry and nutrition · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jisoo LeeDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 03760, Korea. dlwltn233@naver.com.
Yoo-Sun KimDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 03760, Korea. tidygirlss@naver.com.
JaeHwan LeeDepartment of Food Science and Biotechnology, Sungkyunkwan University, Suwon 16419, Korea. s3hun@skku.edu.
Seung Chul HeoDepartment of Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul 07061, Korea. heosc3@brmh.org.
Kook Lae LeeDepartment of Internal Medicine, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul 07061, Korea. kllee@brmh.org.
Sang-Woon ChoiChaum Life Center, CHA University, Seoul 06062, Korea. sangwoon.choi@gmail.com.
Yuri KimDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 03760, Korea. yuri.kim@ewha.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Walnut has been known for its health benefits, including anti-cardiovascular disease and anti-oxidative properties. However, there is limited evidence elucidating its effects on cancer stem cells (CSCs) which represent a small subset of cancer cells that provide resistance against chemotherapy. This study aimed to evaluate the anti-CSCs potential of walnut phenolic extract (WPE) and its bioactive compounds, including (+)-catechin, chlorogenic acid, ellagic acid, and gallic acid. In the present study, CD133⁺CD44⁺ cells were isolated from HCT116 cells using fluorescence-activated cell sorting (FACS) and then treated with WPE. As a result, survival of the CD133⁺CD44⁺ HCT116 cells was inhibited and cell differentiation was induced by WPE. In addition, WPE down-regulated the CSC markers, CD133, CD44, DLK1, and Notch1, as well as the β-catenin/p-GSK3β signaling pathway. WPE suppressed the self-renewal capacity of CSCs. Furthermore, the WPE exhibited stronger anti-CSC effects than its individual bioactive compounds. Finally, the WPE inhibited specific CSC markers in primary colon cancer cells isolated from primary colon tumor. These results suggest that WPE can suppress colon cancer by regulating the characteristics of colon CSCs.

Indexed as

Anticarcinogenic AgentsAntineoplastic Agents, PhytogenicBiomarkers, TumorCatechinCell DifferentiationCell ProliferationCell SurvivalChlorogenic AcidColorectal NeoplasmsDietary SupplementsEllagic AcidGallic AcidHCT116 CellsHumansJuglansNeoplastic Stem CellsAnticarcinogenic AgentsAntineoplastic Agents, PhytogenicBiomarkers, TumorCatechinChlorogenic AcidEllagic AcidGallic AcidPlant Extractsbioactive compoundscancer stem cellscolon cancerself-renewal capacitywalnut phenolic extract

Identifiers

PMID27455311
PMCPMC4963915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.